본문 바로가기
KERD
논문KCI 등재

Role of Endoscopy in Primary Sclerosing Cholangitis

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Primary sclerosing cholangitis (PSC) is a progressive disease of the bile ducts that usually results in chronic liver diseaseoften requiring liver transplantation. Endoscopy remains crucial to the care of these patients, although magnetic resonancecholangiopancreatography has replaced endoscopic retrograde cholangiopancreatography (ERCP) as the primary imaging modalityfor diagnosis. For detection of dysplasia or cholangiocarcinoma, ERCP with intraductal sampling remains compulsory. Moreover,dominant strictures play an important part in the disease development, and management by balloon dilatation or stenting couldcontribute to long-term prognosis. In addition, endoscopy offers management for adverse events such as bile leaks and anastomoticstrictures after liver transplantation. Finally, the special phenotype of inflammatory bowel disease associated with PSC as well as thefrequent occurrence of portal hypertension mandates close follow-up with colonoscopy and upper endoscopy. With the emergenceof novel techniques, the endoscopist remains a key member of the multidisciplinary team caring for PSC patients.

Abstract

Primary sclerosing cholangitis (PSC) is a progressive disease of the bile ducts that usually results in chronic liver diseaseoften requiring liver transplantation. Endoscopy remains crucial to the care of these patients, although magnetic resonancecholangiopancreatography has replaced endoscopic retrograde cholangiopancreatography (ERCP) as the primary imaging modalityfor diagnosis. For detection of dysplasia or cholangiocarcinoma, ERCP with intraductal sampling remains compulsory. Moreover,dominant strictures play an important part in the disease development, and management by balloon dilatation or stenting couldcontribute to long-term prognosis. In addition, endoscopy offers management for adverse events such as bile leaks and anastomoticstrictures after liver transplantation. Finally, the special phenotype of inflammatory bowel disease associated with PSC as well as thefrequent occurrence of portal hypertension mandates close follow-up with colonoscopy and upper endoscopy. With the emergenceof novel techniques, the endoscopist remains a key member of the multidisciplinary team caring for PSC patients.

참고문헌 (60)

  1. Hirschfield GM, "Primary sclerosing cholangitis", Lancet, 382, pp.1587~1599 (2013)
  2. Andersen IM, "Indications and outcomes in liver transplantation in patients with primary sclerosing cholangitis in Norway", Transplant Direct, 1, pp.e39~ (2015)
  3. Schrumpf E, "Primary sclerosing cholangitis-the Norwegian experience", Scand J Gastroenterol, 50, pp.781~796 (2015)
  4. Boonstra K, "Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis", Hepatology, 58, pp.2045~2055 (2013)
  5. Dave M, "Primary sclerosing cholangitis : meta-analysis of diagnostic performance of MR cholangiopancreatography", Radiology, 256, pp.387~396 (2010)
  6. Ponsioen CY, "Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population", Gut, 51, pp.562~566 (2002)
  7. Ponsioen CY, "Validation of a cholangiographic prognostic model in primary sclerosing cholangitis", Endoscopy, 42, pp.742~747 (2010)
  8. Berstad AE, "Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis", Clin Gastroenterol Hepatol, 4, pp.514~520 (2006)
  9. European Society of Gastrointestinal Endoscopy, "Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) clinical guideline", J Hepatol, 66, pp.1265~1281 (2017)
  10. Schramm C, "Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC study group", Hepatology, 66, pp.1675~1688 (2017)
  11. Naess S, "Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease", Liver Int, 34, pp.1488~1495 (2014)
  12. Boberg KM, "Cholangiocarcinoma in primary sclerosing cholangitis : risk factors and clinical presentation", Scand J Gastroenterol, 37, pp.1205~1211 (2002)
  13. Bergquist A, "Hepatic and extrahepatic malignancies in primary sclerosing cholangitis", J Hepatol, 36, pp.321~327 (2002)
  14. Chapman R, "Diagnosis and management of primary sclerosing cholangitis", Hepatology, 51, pp.660~678 (2010)
  15. Kaura K, "Cholangioscopy biopsies improve detection of cholangiocarcinoma when combined with cytology and FISH, but not in patients with PSC", Dig Dis Sci, 65, pp.1471~1478 (2020)
  16. Boberg KM, "Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis", J Hepatol, 45, pp.568~574 (2006)
  17. Hayakawa C, "Bile cytology : a new scoring system for improving diagnostic accuracy", Diagn Cytopathol, 47, pp.641~647 (2019)
  18. Lewis JT, "Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma", Am J Surg Pathol, 34, pp.27~34 (2010)
  19. Boyd S, "Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis", World J Gastroenterol, 23, pp.6147~6154 (2017)
  20. von Seth E, "Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis", Liver Int, 39, pp.382~388 (2019)
  21. Quinn KP, "Clinical implications of serial versus isolated biliary fluorescence in situ hybridization(FISH)polysomy in primary sclerosing cholangitis", Scand J Gastroenterol, 52, pp.377~381 (2017)
  22. Singhi AD, "Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography(ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures", Gut, 69, pp.52~61 (2020)
  23. Chen WM, "Transpapillary biliary biopsy for malignant biliary strictures : comparison between cholangiocarcinoma and pancreatic cancer", World J Surg Oncol, 14, pp.140~ (2016)
  24. Navaneethan U, "Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures : a systematic review and meta-analysis", Gastrointest Endosc, 81, pp.168~176 (2015)
  25. Chen YK, "SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders : a clinical feasibility study(with video)", Gastrointest Endosc, 65, pp.832~841 (2007)
  26. Navaneethan U, "Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders : a multicenter clinical experience(with video)", Gastrointest Endosc, 84, pp.649~655 (2016)
  27. Majeed A, "Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation", Scand J Gastroenterol, 53, pp.56~63 (2018)
  28. Prat F, "Impact of peroral cholangioscopy on the management of indeterminate biliary conditions : a multicentre prospective trial", Frontline Gastroenterol, 10, pp.236~243 (2019)
  29. de Vries AB, "Limited diagnostic accuracy and clinical impact of single-operator peroral cholangioscopy for indeterminate biliary strictures", Endoscopy, 52, pp.107~114 (2020)
  30. Nguyen NQ, "Clinical utility of EUS before cholangioscopy in the evaluation of difficult biliary strictures", Gastrointest Endosc, 78, pp.868~874 (2013)
  31. 여승재, "Comparison of the Diagnostic Performances of Same-session Endoscopic Ultrasound- and Endoscopic Retrograde Cholangiopancreatography-guided Tissue Sampling for Suspected Biliary Strictures at Different Primary Tumor Sites", 대한소화기학회지, 73(4), pp.213~218 (2019), 대한소화기학회[DOI]
  32. Naitoh I, "Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis", J Gastroenterol Hepatol, 30, pp.1104~1109 (2015)
  33. Dubow M, "Individual probe based confocal laser endomicroscopy criteria in the analysis of indeterminate biliary strictures", Scand J Gastroenterol, 53, pp.1358~1363 (2018)
  34. Rizvi S, "Emerging technologies for the diagnosis of perihilar cholangiocarcinoma", Semin Liver Dis, 38, pp.160~169 (2018)
  35. Tyberg A, "Second generation optical coherence tomography : preliminary experience in pancreatic and biliary strictures", Dig Liver Dis, 50, pp.1214~1217 (2018)
  36. Caillol F, "Evaluation of pCLE in the bile duct : final results of EMID study : pCLE : impact in the management of bile duct strictures", Surg Endosc, 29, pp.2661~2668 (2015)
  37. Yang JF, "Diagnostic accuracy of directed cholangioscopic biopsies and confocal laser endomicroscopy in cytology-negative indeterminate bile duct stricture : a multicenter comparison trial", Minerva Gastroenterol Dietol, 62, pp.227~233 (2016)
  38. Ponsioen CY, "Four years experience with short term stenting in primary sclerosing cholangitis", Am J Gastroenterol, 94, pp.2403~2407 (1999)
  39. Björnsson E, "Dominant strictures in patients with primary sclerosing cholangitis", Am J Gastroenterol, 99, pp.502~508 (2004)
  40. Chapman MH, "Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis : a 25-year single-centre experience", Eur J Gastroenterol Hepatol, 24, pp.1051~1058 (2012)
  41. Stiehl A, "Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid : outcome after endoscopic treatment", J Hepatol, 36, pp.151~156 (2002)
  42. Tabibian JH, "Endoscopic management of primary sclerosing cholangitis", Expert Rev Gastroenterol Hepatol, 12, pp.693~703 (2018)
  43. Rupp C, "Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis", Gut, 68, pp.2170~2178 (2019)
  44. Ponsioen CY, "No superiority of stents vs balloon dilatation for dominant strictures in patients with primary sclerosing cholangitis", Gastroenterology, 155, pp.752~759 (2018)
  45. Ismail S, "Risk factors for complications of ERCP in primary sclerosing cholangitis", Endoscopy, 44, pp.1133~1138 (2012)
  46. Navaneethan U, "ERCP-related adverse events in patients with primary sclerosing cholangitis", Gastrointest Endosc, 81, pp.410~419 (2015)
  47. Etzel JP, "Complications after ERCP in patients with primary sclerosing cholangitis", Gastrointest Endosc, 67, pp.643~648 (2008)
  48. Jagtap N, "Is it safe to perform endoscopic retrograde cholangiopancreatography in decompensated cirrhosis?", J Clin Exp Hepatol, 9, pp.554~560 (2019)
  49. Aabakken L, "Double-balloon enteroscopy for endoscopic retrograde cholangiography in patients with a Roux-en-Y anastomosis", Endoscopy, 39, pp.1068~1071 (2007)
  50. Montano-Loza AJ, "Systematic review : recurrent autoimmune liver diseases after liver transplantation", Aliment Pharmacol Ther, 45, pp.485~500 (2017)
  51. Broome U, "Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer", Semin Liver Dis, 26, pp.31~41 (2006)
  52. Jørgensen KK, "Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation : a Nordic multicenter study", Scand J Gastroenterol, 47, pp.1021~1029 (2012)
  53. Treeprasertsuk S, "The predictors of the presence of varices in patients with primary sclerosing cholangitis", Hepatology, 51, pp.1302~1310 (2010)
  54. Cardenas A, "Report of the Baveno VI consensus workshop", Ann Hepatol, 15, pp.289~290 (2016)
  55. Bookwalter CA, "MR elastography in primary sclerosing cholangitis: correlating liver stiffness with bile duct strictures and parenchymal changes", Abdom Radiol(NY), 43, pp.3260~3270 (2018)
  56. Tse Y, "When to perform gastroscopy in the PSC patient", Ann Hepatol, 15, pp.135~136 (2016)
  57. Moctezuma-Velazquez C, "Non-invasive prediction of high-risk varices in patients with primary biliary cholangitis and primary sclerosing cholangitis", Am J Gastroenterol, 114, pp.446~452 (2019)
  58. Jin-Seok Park, "The use of a 532-nm laser fitted with a balloon and a cylindrical light diffuser to treat benign biliary stricture: a pilot study", Lasers in Medical Science, 36(1), pp.25~31 (2021), Springer Science and Business Media LLC[DOI]
  59. Ren H, "Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQbased quantitative proteomics analysis", Oncol Rep, 42, pp.2622~2634 (2019)
  60. Voigtländer T, "Bile and urine peptide marker profiles : access keys to molecular pathways and biological processes in cholangiocarcinoma", J Biomed Sci, 27, pp.13~ (2020)

관련 논문AI추천

Stent versus Balloon Dilation for the Treatment of Dominant Strictures in Primary Sclerosing Cholangitis: A Systematic Review and Meta-AnalysisAlberto Machado da Ponte Neto, Antônio Afonso de Miranda Neto, Diogo Turiani Hourneaux de Moura, Eduardo Guimarães Hourneaux De Moura, Galileu Ferreira Ayala Farias, Igor Braga Ribeiro, Marina Tucci Gammaro Baldavira Ferreira, Pedro Victor Aniz Gomes de Oliveira, Thomas R. McCarty, Wanderley Marques Bernardo대한소화기내시경학회 · Clinical Endoscopy2021 · 제54권 제6호Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific FeaturesCarolina Palmela, Daniel Castaneda, Farhad Peerani, Joana Torres, Steven H. Itzkowitz거트앤리버 소화기연관학회협의회 · Gut and Liver2018 · 제12권 제1호The Role of Peroral Cholangioscopy in Evaluating Indeterminate Biliary StricturesMouen A. Khashab, Nasim Parsa대한소화기내시경학회 · Clinical Endoscopy2019 · 제52권 제6호Endoscopic Evaluation of Biliary Strictures: Current and Emerging TechniquesChristopher Pinto, Corinne Owers, Roy Huynh, Thuy-My Nguyen, Titus Kwok대한소화기내시경학회 · Clinical Endoscopy2021 · 제54권 제6호IgG4-Related Sclerosing Cholangitis and Primary Sclerosing CholangitisAtsushi Tanaka거트앤리버 소화기연관학회협의회 · Gut and Liver2019 · 제13권 제3호Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axisHurley Edward H., Kim You Sun, Ko Sungjin, Park Yoojeong생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권

이 간행물의 다른 논문 (24건)